The impact of preclinical irreproducibility on drug development

Clinical Pharmacology and Therapeutics

Volumn 97, Issue 1, 2015, Pages 16-18

  Freedman, L P ^a   Gibson, M C ^a  

^a Global Biological Standards Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DATA ANALYSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; GOOD LABORATORY PRACTICE; HUMAN; INFORMATION PROCESSING; PEER REVIEW; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; STUDY DESIGN; VALIDITY; DRUG DESIGN; DRUG SCREENING; METHODOLOGY; PROCEDURES; STANDARDS;

DATA COLLECTION; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 84927169932     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.9     Document Type: Review

References (10)

1. Begley, C.G. & Ellis, L.M. Drug development: Raise standards for preclinical cancer research. Nature 483, 531-533 (2012).
2. Global Biological Standards Institute. The Case for Standards in Life Science Research: Seizing Opportunities at a Time of Critical Need (Global Biological Standards Institute, Washington DC, 2013).
3. Rubin, E.H. & Gilliland, D.G. Drug development and clinical trials-the path to an approved cancer drug. Nat. Rev. Clin. Oncol. 9, 215-222 (2012).
4. Freedman, L.P. & Inglese, J. The Increasing urgency for standards in basic biologic research. Cancer Res. 74, 1-6 (2014).
5. Collins, F.S. & Tabak, L.A. NIH plans to enhance reproducibility. Nature 505, 612-613 (2014).
6. Hartshorne, J.K. & Schachner, A. Tracking replicability as a method of postpublication open evaluation. Front. Comput. Neurosci. 6, 1-13 (2012).
7. Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: How much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712 (2011).
8. Vasilevsky, N.A. et al. On the reproducibility of science: Unique identification of research resources in the biomedical literature. PeerJ. 1, e148 (2013).
9. Chakma, J., Sun, G.H., Steinberg, J.D., Sammut, S.M. & Jagsi, R. Asia's ascent-global trends in biomedical R&D expenditures. N. Engl. J. Med. 370, 3-6 (2014).
10. Brazma, A. Minimum information about a microarray experiment (MIAME)-successes, failures, challenges. Scientific-WorldJournal 9, 420-423 (2009).